Competitors of Granules India Ltd in the Pharmaceuticals Sector
| Stock Name | Market Cap | Current Price | High / Low | Stock P/E | Book Value | Dividend Yield | ROCE | ROE | Face Value |
|---|---|---|---|---|---|---|---|---|---|
| MPS Pharmaa Ltd | 8.05 Cr. | 4.21 | 4.33/2.92 | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 | |
| Gujarat Themis Biosyn Ltd | 3,669 Cr. | 337 | 390/189 | 69.6 | 20.5 | 0.20 % | 45.0 % | 33.8 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 61.9 Cr. | 83.4 | 94.9/27.0 | 23.7 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 37.5 Cr. | 25.6 | 27.5/8.74 | 48.7 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
| Godavari Drugs Ltd | 84.6 Cr. | 112 | 155/87.0 | 12.7 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
| Glenmark Life Sciences Ltd | 12,637 Cr. | 1,031 | 1,335/666 | 29.8 | 207 | 2.18 % | 28.1 % | 21.1 % | 2.00 |
| Gennex Laboratories Ltd | 426 Cr. | 18.7 | 29.0/13.2 | 24.6 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.86 Cr. | 16.3 | 27.1/15.0 | 157 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 343 Cr. | 731 | 1,054/650 | 19.4 | 278 | 0.10 % | 17.1 % | 14.3 % | 10.0 |
| Fervent Synergies Ltd | 62.3 Cr. | 20.8 | 27.8/14.6 | 11.8 | 0.00 % | 34.8 % | 34.9 % | 10.0 | |
| Fermenta Biotech Ltd | 1,183 Cr. | 402 | 440/145 | 144 | 98.6 | 0.31 % | 3.20 % | 5.59 % | 5.00 |
| Fabino Enterprises Ltd | 6.91 Cr. | 32.9 | 43.8/23.6 | 138 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
| Evoq Remedies Ltd | 20.3 Cr. | 8.16 | 19.4/7.17 | 45.2 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
| Everest Organics Ltd | 231 Cr. | 289 | 307/110 | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 | |
| Murae Organisor Ltd | 194 Cr. | 2.09 | 3.03/1.03 | 263 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
| Dipna Pharmachem Ltd | 36.0 Cr. | 15.0 | 15.2/6.40 | 43.3 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
| Decipher Labs Ltd | 15.8 Cr. | 15.6 | 24.6/14.4 | 19.0 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
| Coral Laboratories Ltd | 287 Cr. | 805 | 999/345 | 12.4 | 570 | 0.25 % | 12.6 % | 9.58 % | 10.0 |
| Concord Drugs Ltd | 38.5 Cr. | 38.5 | 52.2/30.6 | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 | |
| Colinz Laboratories Ltd | 29.7 Cr. | 65.0 | 84.4/36.0 | 54.0 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
| Cian Healthcare Ltd | 9.15 Cr. | 3.66 | 26.5/3.66 | 36.6 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 15.5 Cr. | 104 | 154/52.2 | 12.4 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
| Checkpoint Trends Ltd | 6.72 Cr. | 12.3 | 17.4/6.08 | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 | |
| Chandra Bhagat Pharma Ltd | 53.6 Cr. | 71.0 | 148/63.0 | 33.9 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
| Brawn Biotech Ltd | 7.17 Cr. | 23.9 | 27.8/14.6 | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 | |
| Bharat Immunological & Biological Corporation Ltd | 109 Cr. | 25.3 | 42.0/22.2 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Beryl Drugs Ltd | 19.0 Cr. | 37.4 | 46.0/22.2 | 55.8 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
| BDH Industries Ltd | 199 Cr. | 345 | 418/226 | 20.4 | 110 | 1.31 % | 20.6 % | 16.9 % | 10.0 |
| Bacil Pharma Ltd | 30.1 Cr. | 51.2 | 62.6/7.03 | 77.3 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
| Aurobindo Pharma Ltd | 77,312 Cr. | 1,319 | 1,593/958 | 21.2 | 527 | 0.34 % | 14.1 % | 11.5 % | 1.00 |
| Auro Laboratories Ltd | 159 Cr. | 255 | 307/121 | 25.8 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
| Anuh Pharma Ltd | 1,134 Cr. | 226 | 265/155 | 19.2 | 60.5 | 1.11 % | 25.6 % | 19.5 % | 5.00 |
| ANG Lifesciences India Ltd | 57.8 Cr. | 44.3 | 77.3/42.0 | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 | |
| Ami Organics Ltd | 8,680 Cr. | 2,121 | 2,363/1,004 | 92.9 | 294 | 0.14 % | 16.0 % | 9.37 % | 10.0 |
| Amerise Biosciences Ltd | 7.86 Cr. | 1.19 | 1.45/0.55 | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 | |
| Ambalal Sarabhai Enterprises Ltd | 435 Cr. | 56.8 | 77.7/39.2 | 32.7 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
| Adline Chem Lab Ltd | 13.0 Cr. | 22.2 | 29.0/11.9 | 2.70 | 0.00 % | % | % | 10.0 | |
| Achyut Healthcare Ltd | 107 Cr. | 4.56 | 6.25/2.87 | 163 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
| Abbott India Ltd | 62,667 Cr. | 29,490 | 30,521/22,948 | 48.8 | 1,657 | 1.39 % | 46.0 % | 34.9 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,078 Cr. | 671 | 722/381 | 26.6 | 205 | 0.45 % | 16.6 % | 13.1 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 167 Cr. | 59.6 | 75.8/37.0 | 24.2 | 48.5 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
| Zota Health Care Ltd | 2,211 Cr. | 807 | 859/440 | 58.0 | 0.12 % | 7.32 % | 16.8 % | 10.0 | |
| Wockhardt Ltd | 24,683 Cr. | 1,519 | 1,583/403 | 221 | 0.00 % | 0.83 % | 12.1 % | 5.00 | |
| Wanbury Ltd | 951 Cr. | 290 | 325/122 | 34.4 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | 0.66 | 0.00 % | 9.38 % | 233 % | 2.00 | |
| Venus Remedies Ltd | 425 Cr. | 318 | 430/280 | 19.2 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
| Unichem Laboratories Ltd | 5,108 Cr. | 726 | 950/433 | 102 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
| TTK Healthcare Ltd | 2,003 Cr. | 1,417 | 1,923/1,232 | 31.0 | 735 | 0.71 % | 8.67 % | 6.43 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,15,163 Cr. | 3,403 | 3,591/2,312 | 66.2 | 222 | 0.82 % | 23.2 % | 24.2 % | 5.00 |
| Themis Medicare Ltd | 2,514 Cr. | 273 | 317/181 | 47.4 | 44.8 | 0.18 % | 13.5 % | 11.8 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,948 Cr. | 20.7 | 27.9/11.0 | 61.3 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
| Suven Pharmaceuticals Ltd | 28,044 Cr. | 1,102 | 1,360/585 | 115 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
| Suven Life Sciences Ltd | 2,811 Cr. | 129 | 169/83.0 | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 | |
| Sun Pharmaceuticals Industries Ltd | 4,43,793 Cr. | 1,850 | 1,960/1,290 | 39.6 | 288 | 0.73 % | 17.3 % | 16.7 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 3,018 Cr. | 697 | 886/322 | 302 | 0.00 % | 8.67 % | 33.5 % | 10.0 | |
| SMS Pharmaceuticals Ltd | 2,166 Cr. | 256 | 398/120 | 36.9 | 70.6 | 0.16 % | 11.2 % | 9.27 % | 1.00 |
| SMS Lifesciences India Ltd | 367 Cr. | 1,215 | 1,750/538 | 18.1 | 621 | 0.12 % | 6.89 % | 3.66 % | 10.0 |
| Shilpa Medicare Ltd | 8,209 Cr. | 839 | 960/313 | 143 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
| Sequent Scientific Ltd | 5,095 Cr. | 204 | 241/91.8 | 239 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
| Sanofi India Ltd | 14,131 Cr. | 6,136 | 7,600/4,606 | 33.5 | 298 | 2.72 % | 71.1 % | 51.5 % | 10.0 |
| RPG Life Sciences Ltd | 3,866 Cr. | 2,338 | 2,977/1,359 | 44.4 | 229 | 0.68 % | 34.6 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,638 Cr. | 5,204 | 5,850/4,637 | 38.1 | 324 | 1.15 % | 45.0 % | 33.5 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 271 Cr. | 77.0 | 87.5/31.9 | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 | |
| Pfizer Ltd | 23,896 Cr. | 5,223 | 6,453/3,950 | 39.0 | 820 | 0.67 % | 22.0 % | 16.1 % | 10.0 |
| Par Drugs & Chemicals Ltd | 263 Cr. | 214 | 348/190 | 14.4 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
| Panacea Biotec Ltd | 2,715 Cr. | 443 | 491/112 | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 | |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Orchid Pharma Ltd | 10,055 Cr. | 1,982 | 1,998/702 | 84.5 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
| Neuland Laboratories Ltd | 17,672 Cr. | 13,774 | 18,100/5,021 | 66.9 | 1,087 | 0.10 % | 33.3 % | 26.4 % | 10.0 |
| Nectar Lifescience Ltd | 902 Cr. | 40.2 | 56.5/26.2 | 84.0 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
| Natco Pharma Ltd | 24,480 Cr. | 1,367 | 1,639/805 | 12.6 | 399 | 0.70 % | 30.1 % | 25.9 % | 2.00 |
| Morepen Laboratories Ltd | 4,327 Cr. | 79.0 | 101/38.6 | 33.0 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
| Marksans Pharma Ltd | 13,500 Cr. | 298 | 359/126 | 39.0 | 50.3 | 0.20 % | 20.6 % | 16.5 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 188 Cr. | 119 | 145/85.2 | 20.0 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
| Lyka Labs Ltd | 584 Cr. | 164 | 177/97.9 | 184 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
| Lupin Ltd | 1,08,075 Cr. | 2,369 | 2,403/1,367 | 41.2 | 343 | 0.34 % | 15.7 % | 14.1 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,712 Cr. | 855 | 980/498 | 17.7 | 319 | 0.21 % | 22.3 % | 16.8 % | 10.0 |
| Laurus Labs Ltd | 32,983 Cr. | 612 | 619/359 | 140 | 79.2 | 0.13 % | 7.50 % | 5.43 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 958 Cr. | 923 | 961/393 | 27.8 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 215 Cr. | 99.9 | 129/60.0 | 60.4 | 0.00 % | 19.0 % | % | 10.0 | |
| Kopran Ltd | 1,029 Cr. | 213 | 370/198 | 19.4 | 103 | 1.41 % | 13.8 % | 11.0 % | 10.0 |
| Kilitch Drugs (India) Ltd | 552 Cr. | 344 | 470/298 | 39.3 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
| Jubilant Pharmova Ltd | 17,393 Cr. | 1,092 | 1,310/532 | 61.1 | 373 | 0.46 % | 6.74 % | 0.76 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 29,050 Cr. | 1,868 | 2,030/1,474 | 47.5 | 207 | 0.66 % | 24.6 % | 20.0 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,742 Cr. | 656 | 820/270 | 65.1 | 74.4 | 0.76 % | 17.0 % | 13.0 % | 5.00 |
| Ipca Laboratories Ltd | 44,018 Cr. | 1,735 | 1,758/1,052 | 70.6 | 264 | 0.23 % | 12.8 % | 9.35 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,499 Cr. | 426 | 538/331 | 24.9 | 283 | 1.17 % | 12.3 % | 8.68 % | 10.0 |
| Ind-Swift Ltd | 162 Cr. | 30.0 | 34.7/14.3 | 2.96 | 122 | 0.00 % | 13.4 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 662 Cr. | 112 | 186/86.2 | 6.48 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
| Indoco Remedies Ltd | 3,101 Cr. | 336 | 415/286 | 139 | 118 | 0.45 % | 10.4 % | 8.33 % | 2.00 |
| Hikal Ltd | 4,881 Cr. | 396 | 465/260 | 66.5 | 97.6 | 0.30 % | 7.79 % | 5.97 % | 2.00 |
| Hester Biosciences Ltd | 2,054 Cr. | 2,415 | 3,379/1,293 | 87.5 | 355 | 0.25 % | 9.32 % | 6.60 % | 10.0 |
| Gufic BioSciences Ltd | 4,756 Cr. | 474 | 504/278 | 56.0 | 57.3 | 0.02 % | 17.2 % | 20.0 % | 1.00 |
| Granules India Ltd | 14,676 Cr. | 605 | 725/382 | 30.1 | 141 | 0.25 % | 15.4 % | 13.4 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 46,169 Cr. | 1,636 | 1,831/767 | 299 | 0.15 % | 12.3 % | 50.9 % | 1.00 | |
| Glaxosmithkline Pharmaceuticals Ltd | 37,965 Cr. | 2,241 | 3,088/1,825 | 47.4 | 98.7 | 1.43 % | 51.3 % | 37.3 % | 10.0 |
| Gland Pharma Ltd | 31,321 Cr. | 1,901 | 2,221/1,586 | 28.4 | 557 | 1.05 % | 16.7 % | 12.3 % | 1.00 |
| FDC Ltd | 8,297 Cr. | 510 | 659/402 | 26.2 | 141 | 0.98 % | 18.4 % | 14.2 % | 1.00 |
| ERIS Lifesciences Ltd | 17,661 Cr. | 1,297 | 1,594/809 | 50.9 | 204 | 0.00 % | 11.3 % | 16.3 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,12,868 Cr. | 1,353 | 1,421/1,104 | 21.1 | 369 | 0.59 % | 26.5 % | 21.4 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 4,531 Cr. | 289 | 308/133 | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 | |
| Cipla Ltd | 1,22,051 Cr. | 1,511 | 1,702/1,266 | 26.5 | 351 | 0.86 % | 22.8 % | 16.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 19,288 Cr. | 2,538 | 2,641/1,221 | 39.1 | 334 | 0.20 % | 26.5 % | 24.2 % | 2.00 |
| Brooks Laboratories Ltd | 502 Cr. | 191 | 196/72.5 | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 | |
| Bliss GVS Pharma Ltd | 1,880 Cr. | 178 | 186/92.2 | 21.3 | 96.0 | 0.28 % | 14.4 % | 10.2 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 100 Cr. | 61.5 | 92.0/53.6 | 189 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
| Biocon Ltd | 44,332 Cr. | 369 | 396/244 | 30.7 | 175 | 0.14 % | 5.96 % | 5.25 % | 5.00 |
| Beta Drugs Ltd | 1,976 Cr. | 2,055 | 2,326/1,060 | 48.2 | 188 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
| Bal Pharma Ltd | 202 Cr. | 127 | 158/89.0 | 26.5 | 43.2 | 0.95 % | 12.1 % | 11.0 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 194 Cr. | 82.0 | 113/73.2 | 252 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
| Astrazeneca Pharma India Ltd | 17,804 Cr. | 7,121 | 8,140/4,050 | 138 | 272 | 0.34 % | 31.1 % | 22.9 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,093 Cr. | 724 | 863/556 | 44.0 | 103 | 0.64 % | 21.3 % | 15.5 % | 1.00 |
| Alpa Laboratories Ltd | 272 Cr. | 129 | 145/69.9 | 13.1 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
| Alkem Laboratories Ltd | 65,792 Cr. | 5,503 | 6,440/4,407 | 30.3 | 961 | 0.73 % | 19.7 % | 19.6 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 20,703 Cr. | 1,053 | 1,304/788 | 32.5 | 249 | 1.04 % | 13.1 % | 13.3 % | 2.00 |
| Albert David Ltd | 790 Cr. | 1,384 | 1,754/1,001 | 11.5 | 724 | 0.83 % | 27.8 % | 21.7 % | 10.0 |
| Ajanta Pharma Ltd | 35,897 Cr. | 2,874 | 3,486/1,998 | 41.0 | 294 | 1.25 % | 31.6 % | 23.2 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 4,011 Cr. | 358 | 571/334 | 27.4 | 120 | 1.42 % | 15.2 % | 11.2 % | 2.00 |
| Aarti Drugs Limited | 4,169 Cr. | 454 | 635/420 | 33.3 | 126 | 0.22 % | 13.7 % | 12.4 % | 10.0 |
| Industry Average | 19,172.63 Cr | 1,202.08 | 57.35 | 184.74 | 0.31% | 16.14% | 16.48% | 6.30 |
